Martin K - Search Results

1

Potential Retinal Biomarkers in Alzheimer's Disease.

García-Bermúdez MY, Vohra R, Freude K, Wijngaarden PV, Martin K, Thomsen MS, Aldana BI, Kolko M. García-Bermúdez MY, et al. Among authors: martin k. Int J Mol Sci. 2023 Oct 31;24(21):15834. doi: 10.3390/ijms242115834. Int J Mol Sci. 2023. PMID: 37958816 Free PMC article. Review.

2

Neuronal Reprogramming for Tissue Repair and Neuroregeneration.

Liou RH, Edwards TL, Martin KR, Wong RC. Liou RH, et al. Int J Mol Sci. 2020 Jun 16;21(12):4273. doi: 10.3390/ijms21124273. Int J Mol Sci. 2020. PMID: 32560072 Free PMC article. Review.

3

Protecting retinal ganglion cells.

Khatib TZ, Martin KR. Khatib TZ, et al. Among authors: martin kr. Eye (Lond). 2017 Feb;31(2):218-224. doi: 10.1038/eye.2016.299. Epub 2017 Jan 13. Eye (Lond). 2017. PMID: 28085136 Free PMC article. Review.

4

Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies.

Whitehead M, Wickremasinghe S, Osborne A, Van Wijngaarden P, Martin KR. Whitehead M, et al. Expert Opin Biol Ther. 2018 Dec;18(12):1257-1270. doi: 10.1080/14712598.2018.1545836. Epub 2018 Nov 14. Expert Opin Biol Ther. 2018. PMID: 30408422 Free PMC article. Review.

5

Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters.

Nieuwenhuis B, Laperrousaz E, Tribble JR, Verhaagen J, Fawcett JW, Martin KR, Williams PA, Osborne A. Nieuwenhuis B, et al. Gene Ther. 2023 Jun;30(6):503-519. doi: 10.1038/s41434-022-00380-z. Epub 2023 Jan 13. Gene Ther. 2023. PMID: 36635457 Free PMC article.

6

Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial.

Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ, Coote M, Trounce IA, Martin KR, van Wijngaarden P, Crowston JG. Hui F, et al. Clin Exp Ophthalmol. 2020 Sep;48(7):903-914. doi: 10.1111/ceo.13818. Epub 2020 Jul 28. Clin Exp Ophthalmol. 2020. PMID: 32721104 Clinical Trial.

7

Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber's Hereditary Optic Neuropathy.

Ratican SE, Osborne A, Martin KR. Ratican SE, et al. Neural Plast. 2018 May 2;2018:7108948. doi: 10.1155/2018/7108948. eCollection 2018. Neural Plast. 2018. PMID: 29853847 Free PMC article. Review.

8

Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.

Osborne A, Khatib TZ, Songra L, Barber AC, Hall K, Kong GYX, Widdowson PS, Martin KR. Osborne A, et al. Among authors: martin kr. Cell Death Dis. 2018 Sep 26;9(10):1007. doi: 10.1038/s41419-018-1041-8. Cell Death Dis. 2018. PMID: 30258047 Free PMC article.

9

Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity.

Kwon HJ, Kong YXG, Tao LW, Lim LL, Martin KR, Green C, Ruddle J, Crowston JG. Kwon HJ, et al. Clin Exp Ophthalmol. 2017 Jul;45(5):472-480. doi: 10.1111/ceo.12916. Epub 2017 Feb 27. Clin Exp Ophthalmol. 2017. PMID: 28134460

10

Genetic engineering and the eye.

Murphy R, Martin KR. Murphy R, et al. Eye (Lond). 2024 Nov 8. doi: 10.1038/s41433-024-03441-2. Online ahead of print. Eye (Lond). 2024. PMID: 39516652 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,160 results

Search Page

Filters